These data suggested that blocked of crosstalk between TAMs and cancer cells may redirect the macrophage function and anti-IL-6 therapy combined with inhibition of STAT-3 signaling may be a useful approach for targeting tumor growth and angiogenesis. Here, IL6 is linked to cancer.